CGH involves comparing the DNA content of a test sample, often derived from a tumor sample, to a normal reference sample. Both DNA samples are labeled with different fluorescent dyes and co-hybridized to a normal metaphase chromosome spread or a microarray. The fluorescence ratios are then analyzed to identify regions of DNA copy number changes.
